Efficacy and safety of dabigatran etexilate and warfarin in "real-world" patients with atrial fibrillation: a prospective nationwide cohort study

Torben Bjerregaard Larsen, Lars Hvilsted Rasmussen, Flemming Skjøth, Karen Margrete Due, Torbjörn Callréus, Mary Rosenzweig, Gregory Y H Lip

Research output: Contribution to journalJournal articleResearchpeer-review

377 Citations (Scopus)
Original languageEnglish
JournalJournal of the American College of Cardiology
Volume61
Issue number22
Pages (from-to)2264-2273
Number of pages10
ISSN0735-1097
DOIs
Publication statusPublished - 4 Jun 2013

Keywords

  • Aged
  • Aged, 80 and over
  • Anticoagulants
  • Antithrombins
  • Atrial Fibrillation
  • Benzimidazoles
  • Denmark
  • Dose-Response Relationship, Drug
  • Drug Prescriptions
  • Female
  • Follow-Up Studies
  • Gastrointestinal Hemorrhage
  • Hospitalization
  • Humans
  • Incidence
  • Intracranial Hemorrhages
  • Logistic Models
  • Male
  • Myocardial Infarction
  • Propensity Score
  • Proportional Hazards Models
  • Prospective Studies
  • Pulmonary Embolism
  • Pyridines
  • Registries
  • Stroke
  • Warfarin

Fingerprint

Dive into the research topics of 'Efficacy and safety of dabigatran etexilate and warfarin in "real-world" patients with atrial fibrillation: a prospective nationwide cohort study'. Together they form a unique fingerprint.

Cite this